193 related articles for article (PubMed ID: 31820437)
21. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
22. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
[TBL] [Abstract][Full Text] [Related]
23. Management of neonatal abstinence syndrome in the newborn nursery.
Artigas V
Nurs Womens Health; 2014 Dec; 18(6):509-14. PubMed ID: 25495971
[TBL] [Abstract][Full Text] [Related]
24. The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome.
Moore JN; Gastonguay MR; Ng CM; Adeniyi-Jones SC; Moody DE; Fang WB; Ehrlich ME; Kraft WK
Clin Pharmacol Ther; 2018 Jun; 103(6):1029-1037. PubMed ID: 29516490
[TBL] [Abstract][Full Text] [Related]
25. Interventions for the Treatment of Neonatal Abstinence Syndrome.
Cook CE; Fantasia HC
Nurs Womens Health; 2019 Aug; 23(4):357-365. PubMed ID: 31251931
[TBL] [Abstract][Full Text] [Related]
26. Breastfeeding promotion for management of neonatal abstinence syndrome.
Pritham UA
J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
[TBL] [Abstract][Full Text] [Related]
27. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
28. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates.
Seligman NS; Salva N; Hayes EJ; Dysart KC; Pequignot EC; Baxter JK
Am J Obstet Gynecol; 2008 Oct; 199(4):396.e1-7. PubMed ID: 18928986
[TBL] [Abstract][Full Text] [Related]
29. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
30. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
31. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
[TBL] [Abstract][Full Text] [Related]
32. An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.
Lai A; Philpot P; Boucher J; Meyer A
Popul Health Manag; 2017 Oct; 20(5):397-401. PubMed ID: 28430046
[TBL] [Abstract][Full Text] [Related]
33. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
[TBL] [Abstract][Full Text] [Related]
35. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome.
Miller JL; Ernst K; Neely SB; Stephens K; Barker P; Skrepnek GH; Johnson PN
J Opioid Manag; 2019; 15(2):159-167. PubMed ID: 31343717
[TBL] [Abstract][Full Text] [Related]
36. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.
Lee J; Hulman S; Musci M; Stang E
Popul Health Manag; 2015 Oct; 18(5):392-7. PubMed ID: 25803316
[TBL] [Abstract][Full Text] [Related]
37. Neonatal Abstinence Syndrome and Corresponding Pharmacotherapy Approaches from 2 University-affiliated Neonatal Intensive Care Units in Puerto Rico (2018-2020).
Morales P; Santiago L; Rosario J; Garcia-Fragoso L; Duconge J; Perez N; Santiago D
P R Health Sci J; 2024 Mar; 43(1):25-31. PubMed ID: 38512758
[TBL] [Abstract][Full Text] [Related]
38. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
39. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence.
Theis JG; Selby P; Ikizler Y; Koren G
Biol Neonate; 1997; 71(6):345-56. PubMed ID: 9197336
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.
Liu T; Lewis T; Gauda E; Gobburu J; Ivaturi V
J Clin Pharmacol; 2016 Aug; 56(8):1009-18. PubMed ID: 26712409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
